Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Intravascular Volumes in Hypoxia During Antarctic Confinement

NCT04106401
completednot_applicable

Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

NCT02652975
completed

Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity

NCT00998465

Clinical Trials (3)

Showing 3 of 3 trials
NCT04106401Not Applicable

Intravascular Volumes in Hypoxia During Antarctic Confinement

Unknown
NCT02652975Not Applicable

Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

Completed
NCT00998465

Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3